ZTAS Treatment Access System
A secure, comprehensive web-accessed patient database which can be accessed by registered healthcare professionals all year round.
Safety and security are at the core of any clozapine service provision and it is essential that mental health organisations have complete confidence in the company which has been granted the privilege of delivering this service for them.
Access to treatment with Zaponex is controlled by ZTAS which is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). ZTAS is managed by a team of fully trained staff who are also able to provide support and guidance on patient-specific enquiries. At ZTAS, we are also able to provide our customers with on-going, locally based training on the ZTAS system as well as a wide range of fact sheets and support materials.
Products & Services
Report Side Effects
Yellow Card Scheme
Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme.
Yellow Card Scheme
